What question did this study set out to answer?

To compare standard chromosome banding with molecular cytogenetic testing using fluorescence in situ hybridization for identifying clinically significant chromosomal abnormalities in acute myeloid leukemia.

May 15, 2002Journal of Clinical Oncology

Comparison of Cytogenetic and Molecular Cytogenetic Detection of Chromosome Abnormalities in 240 Consecutive Adult Patients With Acute Myeloid Leukemia

View Full Paper

Ask AI

Bookmark

Authors

SFStefan FröhlingHeidelberg University SSSilvia SkelinUniversity Hospital Ulm CLClaudia LiebischUniversity Hospital Ulm

Discussion

Member takes

Implication

Prospective cohort study demonstrates improved detection of cryptic chromosome abnormalities in acute myeloid leukemia, indicating that molecular cytogenetics is an essential complementary tool.

Key Points

To compare standard chromosome banding with molecular cytogenetic testing using fluorescence in situ hybridization for identifying clinically significant chromosomal abnormalities in acute myeloid leukemia.
Evaluated 240 consecutive adult patients with acute myeloid leukemia enrolled in the multicenter AML HD93 treatment trial.
Conducted parallel chromosome banding analysis and fluorescence in situ hybridization (FISH) using a comprehensive panel of genomic DNA probes at a single reference laboratory.
FISH uniquely identified two cases of inv(16), three of t(11q23), and three of t(8;21)var that were missed by standard banding, including three cryptic aberrations in cases initially classified as normal karyotypes.
Among 14 patients with no assessable metaphases on conventional banding, FISH successfully identified chromosomal abnormalities in eight cases.
Additional numerical abnormalities, notably +8q and +11q, were uncovered by FISH primarily in patients with complex karyotypes or established disease-specific translocations.

Cite This Study

Fröhling et al. (2002) studied this question.

synapsesocial.com/papers/6a16f2b6b082e78ad77bb5f6 https://doi.org/10.1200/jco.2002.08.155

View Full Paper

Ask AI

Bookmark

Implication

Prospective cohort study demonstrates improved detection of cryptic chromosome abnormalities in acute myeloid leukemia, indicating that molecular cytogenetics is an essential complementary tool.